Baidu
map

pediatrics:心血管危险因素参考值的新模型

2012-05-06 范海珠(编译) 医学论坛网

  最近,《儿科学》(pediatrics)杂志在线发表了法国学者的一项研究。研究人员建立了年龄和性别特异性的心血管危险因素(腰围,收缩压和舒张压,空腹血脂水平,葡萄糖,胰岛素)参考范围,以用于监测欧洲儿童心血管危险因素和制定干预和教育方案。   研究人员在一组具有代表性的健康法国人(年龄介于7~20岁,共1976人,其中男性972人,女性1004人)群中获得了年龄和性别特异性的上述各心血管危险

  最近,《儿科学》(pediatrics)杂志在线发表了法国学者的一项研究。研究人员建立了年龄和性别特异性的心血管危险因素(腰围,收缩压和舒张压,空腹血脂水平,葡萄糖,胰岛素)参考范围,以用于监测欧洲儿童心血管危险因素和制定干预和教育方案。

  研究人员在一组具有代表性的健康法国人(年龄介于7~20岁,共1976人,其中男性972人,女性1004人)群中获得了年龄和性别特异性的上述各心血管危险因素的正常范围。

  研究显示:平均腰围均随男性和女性受试者年龄的增加而增加,但男性腰围略高于女性;收缩压随着年龄的增加逐渐增加,但男性中的相关性曲线较女性陡;舒张压不存在性别差异,因此,将男性和女性受试者的数据汇总创建了舒张压的模型;总胆固醇,高密度脂蛋白胆固醇,低密度脂蛋白胆固醇和甘油三脂水平随年龄和性别的变化有微小变化;血糖和胰岛素水平在青春期达峰值,其中女性的相关曲线较男性陡,反映了青春期的正常的胰岛素抵抗。

      链接:Novel Modeling of Reference Values of Cardiovascular Risk Factors in Children Aged 7 to 20 Years
 



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1958360, encodeId=92d21958360e5, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 11 20:18:00 CST 2012, time=2012-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636501, encodeId=c5851636501ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 02 09:18:00 CST 2012, time=2012-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725421, encodeId=dc711e25421b2, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Nov 12 14:18:00 CST 2012, time=2012-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948883, encodeId=67881948883e5, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Wed Jan 09 12:18:00 CST 2013, time=2013-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331451, encodeId=47d0133145117, content=<a href='/topic/show?id=afab51e831d' target=_blank style='color:#2F92EE;'>#心血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51783, encryptionId=afab51e831d, topicName=心血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629731, encodeId=b48e1629e31db, content=<a href='/topic/show?id=28c351e80dc' target=_blank style='color:#2F92EE;'>#心血管危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51780, encryptionId=28c351e80dc, topicName=心血管危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e0221357465, createdName=lingaifan, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=)]
    2012-08-11 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1958360, encodeId=92d21958360e5, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 11 20:18:00 CST 2012, time=2012-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636501, encodeId=c5851636501ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 02 09:18:00 CST 2012, time=2012-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725421, encodeId=dc711e25421b2, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Nov 12 14:18:00 CST 2012, time=2012-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948883, encodeId=67881948883e5, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Wed Jan 09 12:18:00 CST 2013, time=2013-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331451, encodeId=47d0133145117, content=<a href='/topic/show?id=afab51e831d' target=_blank style='color:#2F92EE;'>#心血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51783, encryptionId=afab51e831d, topicName=心血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629731, encodeId=b48e1629e31db, content=<a href='/topic/show?id=28c351e80dc' target=_blank style='color:#2F92EE;'>#心血管危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51780, encryptionId=28c351e80dc, topicName=心血管危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e0221357465, createdName=lingaifan, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1958360, encodeId=92d21958360e5, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 11 20:18:00 CST 2012, time=2012-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636501, encodeId=c5851636501ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 02 09:18:00 CST 2012, time=2012-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725421, encodeId=dc711e25421b2, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Nov 12 14:18:00 CST 2012, time=2012-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948883, encodeId=67881948883e5, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Wed Jan 09 12:18:00 CST 2013, time=2013-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331451, encodeId=47d0133145117, content=<a href='/topic/show?id=afab51e831d' target=_blank style='color:#2F92EE;'>#心血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51783, encryptionId=afab51e831d, topicName=心血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629731, encodeId=b48e1629e31db, content=<a href='/topic/show?id=28c351e80dc' target=_blank style='color:#2F92EE;'>#心血管危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51780, encryptionId=28c351e80dc, topicName=心血管危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e0221357465, createdName=lingaifan, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=)]
    2012-11-12 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1958360, encodeId=92d21958360e5, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 11 20:18:00 CST 2012, time=2012-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636501, encodeId=c5851636501ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 02 09:18:00 CST 2012, time=2012-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725421, encodeId=dc711e25421b2, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Nov 12 14:18:00 CST 2012, time=2012-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948883, encodeId=67881948883e5, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Wed Jan 09 12:18:00 CST 2013, time=2013-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331451, encodeId=47d0133145117, content=<a href='/topic/show?id=afab51e831d' target=_blank style='color:#2F92EE;'>#心血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51783, encryptionId=afab51e831d, topicName=心血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629731, encodeId=b48e1629e31db, content=<a href='/topic/show?id=28c351e80dc' target=_blank style='color:#2F92EE;'>#心血管危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51780, encryptionId=28c351e80dc, topicName=心血管危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e0221357465, createdName=lingaifan, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1958360, encodeId=92d21958360e5, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 11 20:18:00 CST 2012, time=2012-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636501, encodeId=c5851636501ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 02 09:18:00 CST 2012, time=2012-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725421, encodeId=dc711e25421b2, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Nov 12 14:18:00 CST 2012, time=2012-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948883, encodeId=67881948883e5, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Wed Jan 09 12:18:00 CST 2013, time=2013-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331451, encodeId=47d0133145117, content=<a href='/topic/show?id=afab51e831d' target=_blank style='color:#2F92EE;'>#心血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51783, encryptionId=afab51e831d, topicName=心血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629731, encodeId=b48e1629e31db, content=<a href='/topic/show?id=28c351e80dc' target=_blank style='color:#2F92EE;'>#心血管危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51780, encryptionId=28c351e80dc, topicName=心血管危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e0221357465, createdName=lingaifan, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1958360, encodeId=92d21958360e5, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 11 20:18:00 CST 2012, time=2012-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636501, encodeId=c5851636501ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 02 09:18:00 CST 2012, time=2012-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725421, encodeId=dc711e25421b2, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Nov 12 14:18:00 CST 2012, time=2012-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948883, encodeId=67881948883e5, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Wed Jan 09 12:18:00 CST 2013, time=2013-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331451, encodeId=47d0133145117, content=<a href='/topic/show?id=afab51e831d' target=_blank style='color:#2F92EE;'>#心血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51783, encryptionId=afab51e831d, topicName=心血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629731, encodeId=b48e1629e31db, content=<a href='/topic/show?id=28c351e80dc' target=_blank style='color:#2F92EE;'>#心血管危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51780, encryptionId=28c351e80dc, topicName=心血管危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e0221357465, createdName=lingaifan, createdTime=Mon May 07 15:18:00 CST 2012, time=2012-05-07, status=1, ipAttribution=)]

相关资讯

慢病管理中应重视糖尿病与心血管疾病的关系

  3月30日,由首都医科大学附属北京安贞医院内分泌科主办的“2012年糖尿病与心血管疾病临床诊治研讨会”在京召开,会上主要讨论了糖尿病合并冠心病手术方式的选择、如何降低糖尿病患者的心血管风险及如何全面管理老年糖尿病患者等问题。参会医生中有不少来自社区医疗卫生服务机构的全科医生,共同探讨了一些慢病管理中遇到的糖尿病与心血管疾病相关问题,明确了重视两种疾病的关系、个体化处理是

BMJ:联用二甲双胍和胰岛素或不优于单用胰岛素

  丹麦一项研究报告,与单用胰岛素相比,并无证据显示对2型糖尿病患者联用二甲双胍与胰岛素可减少全因死亡或心血管死亡。研究4月19日发表于《英国医学杂志》(BMJ)。   该研究对23项随机试验(n=2117)行荟萃分析和试验序贯分析。结果显示,与单用胰岛素相比,联用二甲双胍和胰岛素未显著影响全因死亡[相对危险(RR)=1.30,95%可信区间(CI)0.57~2.99]和心血管死亡(RR=1.7

代谢性心血管危险因素的年龄相关性存在人群差异

  多国学者的一项研究表明,主要代谢性心血管病危险因素随年龄增加而升高的情况在不同人群中差异明显,空腹血糖和总胆固醇表现尤为显著。论文于2012年4月4日在线发表于《循环》(Circulation)杂志。   年龄相关性心血管病可能部分由其代谢危险因素倾向于随年龄增加而升高所致。在同一人群中分析年龄相关性多重代谢风险的研究较为匮乏。此项研究利用了来自52个国家的83项全国性或亚全国性健康调

贝特与老年急性肾脏转归有关

  《内科医学杂志》[Ann Intern Med;2012,156(8):560-569]4月17日发表的一项研究表明,开始使用贝特治疗的老年患者,由于血清肌酐水平的升高而导致住院危险升高。   该研究基于一个加拿大的数据库,比较了19000例66岁以上处方贝特的老人,和近62000例使用依折麦布新处方的老年人。研究者发现,在治疗的前90天,贝特的应用导致的因肌酐水平升高而

FDA添加屈螺酮VTE风险警示标签

  4月10日,美国FDA表示将为所有含屈螺酮的避孕药添加VTE风险警示标签。   一些近期的流行病学研究报告,含有屈螺酮的避孕药与含有其他孕激素类的药物如左炔诺孕酮相比,静脉血栓栓塞事件(VTE)风险升高3倍。不过,也有其他研究未发现含屈螺酮的药物有额外VTE风险。   FDA指出,除了含有屈螺酮的药物与不含屈螺酮的药物的VTE相对危险估计不一致外,研究并没有解释可能影响处方及可能影响血栓危

预防心血管事件应全面干预危险因素

  美国一项研究纳入9251例低密度脂蛋白胆固醇<130 mg/dl的冠心病患者,随机分为2组,每日分别予阿托伐他汀10 mg和80 mg,中位随访时间4.9年,观察严重不良心脏事件的发生风险。结果显示,患者该风险升高的决定因素除了吸烟、既往的心血管疾病、钙离子拮抗剂使用外,还包括高龄、BMI高于正常范围、男性、高血压、糖尿病、载脂蛋白B的基线水平及血尿素氮水平,而风

Baidu
map
Baidu
map
Baidu
map